Počet záznamov: 1
pioglitazón
SYS d000077205 LBL 00000cx^^^2200181-^^45^^ 005 20240119200811.2 100 $a 20190101asloy0103 ba0 152 $b mesh 250 $a pioglitazón $x AA $x AD $x AE $x AG $x AI $x AN $x BL $x CF $x CH $x CL $x CS $x EC $x HI $x IM $x IP $x ME $x PD $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UR $8 slo 300 1-
$a 2019 (1989) $8 eng 330 1-
$a A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS. $8 eng 450 $a Pioglitazone Hydrochloride $5 e $8 eng 450 $a 5-(4-(2-(5-etyl-2-pyridyl)etoxy)benzyl)-2,4-tiazolidíndión $5 e $8 slo 450 $a Actos $5 e $8 slo 450 $a pioglitazón hydrochlorid $5 e $8 slo 550 $3 sllk_un_auth*d000077154 $Y Rosiglitazone $5 B $a rosiglitazón 550 $3 sllk_un_auth*d000077154 $Y Rosiglitazone $5 F $a rosiglitazón 686 $a D02.886.675.933.250 686 $a D03.383.129.708.933.250 750 $a Pioglitazone $8 eng 801 -0
$a SK $b BA006 $c 20190310 801 -2
$a SK $b BA006 $c 20190619 801 -2
$a SK $b BA006 $c 20190705 801 -2
$a SK $b BA006 $c 20200917 980 $x M
Počet záznamov: 1